Cutler Group’s Celularity CELU Stock Holding History

Cutler Group’s Portfolio CELU Stock Details CELU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-360	Closed	-$34K	–	4464
2022 Q3	$34K	Sell	360 -1,120	-76%	-$34K	﹤0.01%	2185
2022 Q2	$88K	Buy	1,480 +1,050	+244%	+$85.3K	0.01%	1518
2022 Q1	$17K	Sell	430 -460	-52%	-$27.6K	﹤0.01%	3181
2021 Q4	$21K	Sell	890 -1,920	-68%	-$123K	﹤0.01%	3073
2021 Q3	$178K	Buy	2,810 +2,420	+621%	+$195K	0.01%	1448
2021 Q2	$3K	Buy	+390	New	+$39.5K	﹤0.01%	4732

Other funds holding CELU

SIC

Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return

CVSC

C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BFO

Biltmore Family Office Charlotte, North Carolina $761M AUM 31.91% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Cutler Group's CELU Position: Q1 2023 in Review

Cutler Group sold out of Celularity (CELU) in Q1 2023, closing a stake of 20 shares — an estimated $161 sold.

Cutler Group first reported a position in CELU in Q1 2021 and held it in 7 quarters. The position peaked at $279K in Q1 2021. 61 funds tracked by Wall St. Rank hold CELU as of Q1 2023.

Cutler Group reported no remaining Celularity position as of Q1 2023 after selling out during the quarter.
Cutler Group sold 20 Celularity shares in Q1 2023, an estimated $161.
Cutler Group first reported a position in Celularity in Q1 2021 and held it in 7 quarters.
Cutler Group's Celularity position peaked at $279K in Q1 2021.
61 funds tracked by Wall St. Rank held Celularity as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.